Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKesson
Moodys
Boehringer Ingelheim
AstraZeneca

Last Updated: September 26, 2022

Drugs with Dosage: TROCHE/LOZENGE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drugs with Dosage: TROCHE/LOZENGE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Aurobindo Pharma Ltd NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 213266-001 Aug 3, 2021 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
Aurobindo Pharma Ltd NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 213266-002 Aug 3, 2021 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
Dr Reddys Labs Sa NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 213233-001 Aug 4, 2020 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
Dr Reddys Labs Sa NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 213233-002 Aug 4, 2020 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
Dr Reddys Labs Sa NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 212983-001 Feb 21, 2020 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
Dr Reddys Labs Sa NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 212983-002 Feb 21, 2020 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing TROCHE/LOZENGE;ORAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Dow
Harvard Business School
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.